Ethyl 3-Piperidinecarboxylate

Name: Ethyl 3-Piperidinecarboxylate | 5006-62-2
Brand: US-CATO
SKU: S57C1920354_25_MG
Price: 19998.0 USD
Availability: OutOfStock

Cat. No S57C1920354_25_MG

Vendor: US-CATO

Product Information

Product Name

Ethyl 3-Piperidinecarboxylate

Brand Name

US-CATO

Product Number

C1920354

CAS

5006-62-2

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

98969

IUPAC Name

ethyl piperidine-3-carboxylate

InChI Key

XIWBSOUNZWSFKU-UHFFFAOYSA-N

SMILES

CCOC(=O)C1CCCNC1

References Data Source From Pubchem

A neural substrate of comorbid depressive symptoms in alcohol use

Publication Name: Molecular Psychiatry

Publication Date: 2025-05-27

DOI: 10.1038/s41380-025-03061-6

Design and development of an efficient convergent synthetic strategy for novel β-lactam enhancer zidebactam (WCK 5107)

Publication Name: Chemical Papers

Publication Date: 2023-11-12

DOI: 10.1007/s11696-023-03176-6

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Publication Name: Science (New York, N.Y.)

Publication Date: 2023-11-10

DOI: 10.1126/science.abo7201

An insight on medicinal attributes of 1,2,3‐ and 1,2,4‐triazole derivatives as alpha-amylase and alpha-glucosidase inhibitors

Publication Name: Molecular Diversity

Publication Date: 2023-09-21

DOI: 10.1007/s11030-023-10728-1

Structure activity relationship (SAR) driven design and discovery of WCK 5107 (Zidebactam): novel β-lactam enhancer, potent against multidrug-resistant gram-negative pathogens

Publication Name: Medicinal Chemistry Research

Publication Date: 2023-08-09

DOI: 10.1007/s00044-023-03135-6

Ethyl 3-Piperidinecarboxylate

Product Information

General Information

References Data Source From Pubchem

A neural substrate of comorbid depressive symptoms in alcohol use

Design and development of an efficient convergent synthetic strategy for novel β-lactam enhancer zidebactam (WCK 5107)

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

An insight on medicinal attributes of 1,2,3‐ and 1,2,4‐triazole derivatives as alpha-amylase and alpha-glucosidase inhibitors

Structure activity relationship (SAR) driven design and discovery of WCK 5107 (Zidebactam): novel β-lactam enhancer, potent against multidrug-resistant gram-negative pathogens